Allergy & Immunologybiologic eligibilityblood eosinophils
Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data
By MedXY|Oct 11, 2026
A large UK study reveals that over two-thirds of biologic-eligible severe asthma patients improve without biologic therapy, identifying distinct exacerbation trajectories linked to blood eosinophil levels and disease phenotype.